Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chandran

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
Nature Communications|March 3, 2011
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground stateR Patani, A J Hollins, T M Wishart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Identification of an Immunogenic Subset of Metastatic Uveal MelanomaLuke D Rothermel, Arvind C Sabesan, Daniel J Stephens, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
JCI Insight|December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapyChristopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
The Lancet. Oncology|April 12, 2017
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 studySmita S Chandran, Robert P T Somerville, James C Yang, et al.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled AnalysisDorra Bouazzi, Rune K Andersen, Gabrielle R Vinding, et al.
Brain Research|March 1, 2016
Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbationsB Mollereau, N M Rzechorzek, B D Roussel, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Nature Communications|March 3, 2011
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground stateR Patani, A J Hollins, T M Wishart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Identification of an Immunogenic Subset of Metastatic Uveal MelanomaLuke D Rothermel, Arvind C Sabesan, Daniel J Stephens, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
JCI Insight|December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapyChristopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
The Lancet. Oncology|April 12, 2017
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 studySmita S Chandran, Robert P T Somerville, James C Yang, et al.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled AnalysisDorra Bouazzi, Rune K Andersen, Gabrielle R Vinding, et al.
Brain Research|March 1, 2016
Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbationsB Mollereau, N M Rzechorzek, B D Roussel, et al.
Pageof 24